10-Q Filing

CVS HEALTH CORP CIK: 64803 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0000064803-22-000038`
Period End Date	20220930
Filing Date	20221102
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	cvs-20220930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 107 Income Statement 100 Cash Flow Statement 100 Stockholders Equity 79 Comprehensive Income 44

Balance Sheet 107 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.20B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.83B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.41B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$2.79B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$3.12B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$26.32B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$24.43B	USD	Point-in-time
Inventories	`InventoryNet`	$18.06B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$17.76B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$1.50B	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.29B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.48B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.74B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.76B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.32B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.31B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$68.34B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$60.01B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$23.02B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	422.00M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	442.00M	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$20.57B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.90B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.63B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$19.12B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$18.27B	USD	Point-in-time
Goodwill	`Goodwill`	$78.09B	USD	Point-in-time
Goodwill	`Goodwill`	$79.12B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$25.16B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$29.03B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$3.32B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$5.09B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.85B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.71B	USD	Point-in-time
Total assets	`Assets`	$231.21B	USD	Point-in-time
Total assets	`Assets`	$233.00B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$12.54B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$13.93B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$19.16B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$17.33B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$10.35B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$8.81B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$1.64B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$4.30B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$19.42B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$17.67B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.30B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$4.56B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.65B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.69B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$1.36B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$4.21B	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$296.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$67.81B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$72.41B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.18B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$17.17B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$51.97B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$50.85B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.51B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$6.27B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$5.09B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.32B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$6.40B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$6.17B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.90B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$6.77B	USD	Point-in-time
Total liabilities	`Liabilities`	$157.62B	USD	Point-in-time
Total liabilities	`Liabilities`	$160.20B	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,757 shares issued and 1,315 shares outstanding at September 30, 2022 and 1,744 shares issued and 1,322 shares outstanding at December 31, 2021 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$48.05B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,757 shares issued and 1,315 shares outstanding at September 30, 2022 and 1,744 shares issued and 1,322 shares outstanding at December 31, 2021 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$47.38B	USD	Point-in-time
Treasury stock, at cost: 442 shares at September 30, 2022 and 422 shares at December 31, 2021	`TreasuryStockValue`	$28.17B	USD	Point-in-time
Treasury stock, at cost: 442 shares at September 30, 2022 and 422 shares at December 31, 2021	`TreasuryStockValue`	$30.33B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$54.91B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$54.57B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.61B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$965.00M	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$75.08B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$70.68B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$306.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$328.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.16B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.14B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.56B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.51B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.62B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.38B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.01B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$233.00B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$231.21B	USD	Point-in-time

Income Statement 100 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$56.93B	USD	3 Qtrs
Premiums	`PremiumsEarnedNet`	$18.98B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$63.89B	USD	3 Qtrs
Premiums	`PremiumsEarnedNet`	$21.00B	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$515.00M	USD	3 Qtrs
Net investment income	`NetInvestmentIncome`	$201.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$832.00M	USD	3 Qtrs
Net investment income	`NetInvestmentIncome`	$246.00M	USD	1 Quarter
Total revenues	`Revenues`	$73.79B	USD	1 Quarter
Total revenues	`Revenues`	$238.62B	USD	3 Qtrs
Total revenues	`Revenues`	$81.16B	USD	1 Quarter
Total revenues	`Revenues`	$215.51B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$129.43B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$50.37B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$45.01B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$145.16B	USD	3 Qtrs
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$47.69B	USD	3 Qtrs
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$17.42B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$52.98B	USD	3 Qtrs
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$16.08B	USD	1 Quarter
Opioid litigation charges	`GainLossRelatedToLitigationSettlement`	-	USD	3 Qtrs
Opioid litigation charges	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Opioid litigation charges	`GainLossRelatedToLitigationSettlement`	$-5.22B	USD	1 Quarter
Opioid litigation charges	`GainLossRelatedToLitigationSettlement`	$-5.70B	USD	3 Qtrs
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$2.48B	USD	1 Quarter
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	-	USD	3 Qtrs
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$2.52B	USD	3 Qtrs
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	-	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	$431.00M	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	$431.00M	USD	1 Quarter
Operating expenses	`OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement`	$9.61B	USD	1 Quarter
Operating expenses	`OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement`	$9.21B	USD	1 Quarter
Operating expenses	`OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement`	$28.13B	USD	3 Qtrs
Operating expenses	`OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement`	$27.00B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$70.73B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$204.54B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$234.49B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$85.09B	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$4.13B	USD	3 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$3.06B	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$10.96B	USD	3 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-3.93B	USD	1 Quarter
Interest expense	`InterestExpense`	$1.90B	USD	3 Qtrs
Interest expense	`InterestExpense`	$566.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$602.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.74B	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-363.00M	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-363.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$144.00M	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$41.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$49.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$126.00M	USD	3 Qtrs
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$8.85B	USD	3 Qtrs
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.15B	USD	1 Quarter
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-4.46B	USD	1 Quarter
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.52B	USD	3 Qtrs
Income tax provision (benefit)	`IncomeTaxExpenseBenefit`	$558.00M	USD	1 Quarter
Income tax provision (benefit)	`IncomeTaxExpenseBenefit`	$-1.05B	USD	1 Quarter
Income tax provision (benefit)	`IncomeTaxExpenseBenefit`	$654.00M	USD	3 Qtrs
Income tax provision (benefit)	`IncomeTaxExpenseBenefit`	$2.25B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$2.79B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.22B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.31B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-3.41B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.96B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.86B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$1.59B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$6.60B	USD	3 Qtrs
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$18.00M	USD	3 Qtrs
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.00M	USD	3 Qtrs
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-11.00M	USD	1 Quarter
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.00M	USD	1 Quarter
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$-3.42B	USD	1 Quarter
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$6.60B	USD	3 Qtrs
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$1.60B	USD	1 Quarter
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$1.85B	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-2.60	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.21	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$5.01	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.41	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$4.98	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-2.60	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.40	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.20	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.32B	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.32B	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.31B	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.33B	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.33B	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.32B	shares	3 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.50	USD	3 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.55	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.65	USD	3 Qtrs

Cash Flow Statement 100 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$235.40B	USD	3 Qtrs
Cash receipts from customers	`ProceedsFromCustomers`	$209.10B	USD	3 Qtrs
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$138.78B	USD	3 Qtrs
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$122.13B	USD	3 Qtrs
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$46.97B	USD	3 Qtrs
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$51.43B	USD	3 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$22.37B	USD	3 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$21.84B	USD	3 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$327.00M	USD	3 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$582.00M	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$1.94B	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$2.10B	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$2.40B	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$3.07B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$14.26B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$18.13B	USD	3 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$5.54B	USD	3 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$5.56B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$6.44B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$7.42B	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.92B	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.04B	USD	3 Qtrs
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$131.00M	USD	3 Qtrs
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$135.00M	USD	3 Qtrs
Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,808 and $0)	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$-1.93B	USD	3 Qtrs
Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,808 and $0)	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	-	USD	3 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-74.00M	USD	3 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-95.00M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-4.93B	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.82B	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$987.00M	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$7.82B	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$4.20B	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$2.00B	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$2.19B	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.97B	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$510.00M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$440.00M	USD	3 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$161.00M	USD	3 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$337.00M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-119.00M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$80.00M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-8.44B	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-8.33B	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.00B	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$4.87B	USD	3 Qtrs
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.04B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.56B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.69B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.04B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.04B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.56B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.69B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.04B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$2.79B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.22B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.31B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-3.41B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.96B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.86B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$1.59B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$6.60B	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.40B	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.20B	USD	3 Qtrs
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$2.48B	USD	1 Quarter
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	-	USD	3 Qtrs
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$2.52B	USD	3 Qtrs
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	-	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	$431.00M	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	$431.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$341.00M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$346.00M	USD	3 Qtrs
Gain on sale of subsidiary	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Gain on sale of subsidiary	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Gain on sale of subsidiary	`GainLossOnSaleOfBusiness`	$225.00M	USD	3 Qtrs
Gain on sale of subsidiary	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-363.00M	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-363.00M	USD	1 Quarter
Deferred income taxes and other noncash items	`DeferredIncomeTaxesAndOtherNoncashItems`	$-645.00M	USD	3 Qtrs
Deferred income taxes and other noncash items	`DeferredIncomeTaxesAndOtherNoncashItems`	$-2.25B	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$3.50B	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$2.01B	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-1.10B	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$415.00M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$311.00M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$88.00M	USD	3 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$3.35B	USD	3 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$3.97B	USD	3 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$348.00M	USD	3 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$4.69B	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$7.38B	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$1.94B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$14.26B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$18.13B	USD	3 Qtrs

Stockholders Equity 79 line items

Line Item	Tag	Value	Unit	Period
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.16B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.14B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.56B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.51B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.62B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.38B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.01B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$2.79B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.22B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.31B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-3.41B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.96B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.86B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$1.59B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$6.60B	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-392.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-798.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-2.57B	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-93.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-337.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-621.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$148.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-1.16B	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$268.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$173.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$300.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$214.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$197.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$138.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$150.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$1.97B	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$267.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$86.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$86.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$76.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$729.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$730.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$665.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$655.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$723.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$660.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-1.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$2.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-1.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$1.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$3.00M	USD	1 Quarter
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.16B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.14B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.56B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.51B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.62B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.38B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.01B	USD	Point-in-time

Comprehensive Income 44 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$2.79B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.22B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.31B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-3.41B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.96B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.86B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$1.59B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$6.60B	USD	3 Qtrs
Net unrealized investment losses	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-623.00M	USD	1 Quarter
Net unrealized investment losses	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-73.00M	USD	1 Quarter
Net unrealized investment losses	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-2.59B	USD	3 Qtrs
Net unrealized investment losses	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-310.00M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-5.00M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-6.00M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-5.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-7.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-22.00M	USD	3 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$20.00M	USD	3 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$8.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-15.00M	USD	1 Quarter
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-1.00M	USD	3 Qtrs
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-1.00M	USD	1 Quarter
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	1 Quarter
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-2.00M	USD	3 Qtrs
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-392.00M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-798.00M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-2.57B	USD	3 Qtrs
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-93.00M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-337.00M	USD	3 Qtrs
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-621.00M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$148.00M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-1.16B	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-4.03B	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$6.26B	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.49B	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-709.00M	USD	3 Qtrs
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$18.00M	USD	3 Qtrs
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.00M	USD	3 Qtrs
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-11.00M	USD	1 Quarter
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.00M	USD	1 Quarter
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.50B	USD	1 Quarter
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$-727.00M	USD	3 Qtrs
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$6.27B	USD	3 Qtrs
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$-4.04B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.